Absci to Report Business Updates and First Quarter 2026 Financial and Operating Results on May 7, 2026
Summary
VANCOUVER, Wash. and NEW YORK, April 23, 2026 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a clinical-stage biopharmaceutical company advancing breakth...
Description
VANCOUVER, Wash. and NEW YORK, April 23, 2026 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a clinical-stage biopharmaceutical company advancing breakth...
Original reporting
AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.
Open original source